3rd Quarter - Termination

ZYMERGEN INC. for ZYMERGEN INC.

Period 3rd Quarter 2021 Filed Oct 20, 2021 Signed by Mina Kim

Official filing
Firm
ZYMERGEN INC.
Client
ZYMERGEN INC.
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 30, 2021

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Issues related to domestic biomanufacturing investment; pharmaceutical supply chain resilience; biomedicine, biotech, and the bioeconomy

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
ANNA JONES —

Contacted: Executive Office of the President (EOP); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.